Chargement de votre page…
Actas dermo-sifiliograficas
Par González Cantero Á, Ferrán M, Pérez Barrio S et 4 autres.
Contenu en anglais
Scalp psoriasis affects approximately 80% of patients with psoriasis and presents therapeutic challenges related to treatment adherence, formulation selection, and quality of life. Updated management recommendations are needed.
Ward réunit ces articles dans la même app que vos cartes et vos questions. Un seul compte gratuit pour Ward, Suture, Osler et Prognia.
A Delphi consensus study involving 53 dermatologists from the Psoriasis Working Group of the Spanish Academy of Dermatology and Venereology (AEDV) was conducted. Following a literature review, experts evaluated 47 recommendations using a 7-point Likert scale, with consensus defined as at least 75% agreement or disagreement. Preferences for topical vehicles and systemic treatments were also assessed.
Consensus was reached on 34 recommendations. Topical corticosteroids, particularly high-potency agents, were recommended as first-line treatment. Combinations with vitamin D analogues were supported for initial and maintenance therapy, while keratolytic agents combined with corticosteroids were considered appropriate for severe scaling. Scalp-compatible formulations, including lotions, solutions, shampoos, gels, and creams using Polyaphron Dispersion (PAD) technology, were favored. Systemic treatment was considered appropriate for severe symptoms or impaired quality of life, with IL-17 and IL-23 inhibitors receiving the highest preference scores (8.84 and 8.32, respectively).
This Delphi consensus provides updated, clinically applicable recommendations for scalp psoriasis management, emphasizing effective topical therapies, appropriate formulations, treatment adherence, and individualized systemic treatment selection.
Publié dans Actas dermo-sifiliograficas. Le résumé est reproduit tel qu’il a été publié et reste l’œuvre de ses auteurs ; lisez l’article complet à la source.
Prognia référence cet article à des fins de documentation et de formation. Il ne constitue pas un avis médical. Lisez toujours l’original et suivez les recommandations en vigueur et les protocoles locaux avant d’agir.
